Morning Buzz: Aerie Pharmaceuticals (AERI), Acura (ACUR), Great Basin Scientific (GBSN), Coty Inc. (COTY)
June 16, 2015 at 10:00 AM EDT
Shares of Aerie Pharmaceuticals, Inc. (AERI) are higher by nearly 47% to $19.50 in early trade on Tuesday after the company reported that the FDA has agreed in written and verbal communications that Aerie may change the primary endpoint range of its second Phase 3 registration trial of RhopressaTM, named Rocket 2. “We are extremely […] View the full post at: Morning Buzz: Aerie Pharmaceuticals (AERI), Acura (ACUR), Great Basin Scientific (GBSN), Coty Inc. (COTY) Related posts: Great Basin Bank of Nevada Fails CA: Great Value Play Star Scientific (CIGX) Announces Collaboration with Roskamp Institute on Alzheimer’s Disease